HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Brigitte Greiner Selected Research

LAV694

11/2003LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Brigitte Greiner Research Topics

Disease

2Inflammation (Inflammations)
06/2005 - 11/2003
2Neoplasms (Cancer)
11/2003 - 01/2002
1Uveitis
06/2005
1Glaucoma
06/2005
1Actinic Keratosis
11/2003
1Necrosis
11/2003
1Body Weight (Weight, Body)
11/2003

Drug/Important Bio-Agent (IBA)

1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2005
1Dopamine (Intropin)FDA LinkGeneric
06/2005
1EndotoxinsIBA
06/2005
1Antiglaucoma AgentsIBA
06/2005
1Timolol (Blocadren)FDA LinkGeneric
06/2005
1Proteins (Proteins, Gene)FDA Link
06/2005
1LAV694IBA
11/2003
1Phosphotransferases (Kinase)IBA
11/2003
1Biological ProductsIBA
11/2003
1Paclitaxel (Taxol)FDA LinkGeneric
11/2003
1Growth Factor ReceptorsIBA
11/2003
1A 19IBA
11/2003

Therapy/Procedure

2Lasers (Laser)
11/2003 - 01/2002
1Topical Administration
06/2005